Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 900 of 1467 entries
View as:

A Study to Evaluate Impact of Efanesoctocog Alfa on Long-term Joint Health in Participants With Hemophilia A in Taiwan

Phase: N/A Priority: Normal
NCT ID: NCT06684314 Org: User:
Start: 01/13/24 End: 08/28/31 Due: 08/28/32

Dupilumab for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite the Use of H1 Antihistamine and Who Are naïve to, Intolerant of, or Incomplete Responders to Omalizumab (LIBERTY-CSU CUPID)

Phase: N/A Priority: Normal
NCT ID: NCT04180488 Org: User:
Start: 12/11/19 End: 10/25/24 Due: 10/25/25

Efficacy and Safety of SL77.0499-10 (Alfuzosin) Versus Placebo and Tamsulosin in Japanese Patients With Benign Prostatic Hyperplasia

Phase: N/A Priority: Normal
NCT ID: NCT00399464 Org: User:
Start: 11/30/06 End: 10/31/07 Due: 10/31/08

A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT06867094 Org: User:
Start: 03/28/25 End: 05/11/28 Due: 05/11/29

Efanesoctocog Alfa Prophylaxis in Patients With Hemophilia A With Synovial Hypertrophy

Phase: N/A Priority: Normal
NCT ID: NCT06941870 Org: User:
Start: 05/30/25 End: 06/15/27 Due: 06/15/28

Study of the Tolerability and Pharmacokinetics of Oral Doses of SAR442168 With a Food Effect Investigation in Healthy Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT06106074 Org: User:
Start: 08/10/20 End: 05/23/22 Due: 05/23/23

EURopean Trial In Atrial Fibrillation(AF) or Flutter (AFL) Patients Receiving Dronedarone for the maIntenance of Sinus Rhythm (EURIDIS)

Phase: N/A Priority: Normal
NCT ID: NCT00259428 Org: User:
Start: 11/30/01 End: 08/31/03 Due: 08/31/04

Efficacy and Safety Study of Dupilumab in Patients With Persistent Asthma

Phase: N/A Priority: Normal
NCT ID: NCT03782532 Org: User:
Start: 01/25/19 End: 05/21/22 Due: 05/21/23

Single and Repeated Dosing Study to Assess the Safety and the Concentration-time Profile of SAR228810 in Alzheimer's Patients

Phase: N/A Priority: Normal
NCT ID: NCT01485302 Org: User:
Start: 01/31/12 End: 02/28/15 Due: 02/28/16

Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Ezetimibe in Patients With Hypercholesterolemia

Phase: N/A Priority: Normal
NCT ID: NCT01644474 Org: User:
Start: 07/31/12 End: 07/31/13 Due: 07/31/14

Evaluation of the Effect of AVE0657 in Cheynes-Stokes Breathing Syndrome Patients

Phase: N/A Priority: Normal
NCT ID: NCT00694720 Org: User:
Start: 06/30/08 End: 03/31/09 Due: 03/31/10

Food Effect Study on Pharmacodynamic and Bioavailability of Clopidogrel 300/75 mg in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01129271 Org: User:
Start: 04/30/09 End: 06/30/09 Due: 06/30/10

Phase III Study To Evaluate Alirocumab in Patients With Hypercholesterolemia Not Treated With a Statin (ODYSSEY CHOICE II)

Phase: N/A Priority: Normal
NCT ID: NCT02023879 Org: User:
Start: 12/16/13 End: 06/30/17 Due: 06/30/18

Leflunomide + Methotrexate in Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00563849 Org: User:
Start: 05/31/03 End: 08/31/04 Due: 08/31/05

First in Human Testing of Dose-escalation of SAR440234 in Patients With Acute Myeloid Leukemia, Acute Lymphoid Leukemia and Myelodysplastic Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT03594955 Org: User:
Start: 10/24/18 End: 02/06/21 Due: 02/06/22

Effect of Lixisenatide on Postprandial Plasma Glucose Compared to Sitagliptin in Combination With Insulin Glargine

Phase: N/A Priority: Normal
NCT ID: NCT02200991 Org: User:
Start: 08/31/14 End: 11/30/15 Due: 11/30/16

Dermacyd PH_DETINLYN Tangerine Mix (Lactic Acid) - Photo Evaluation

Phase: N/A Priority: Normal
NCT ID: NCT00784056 Org: User:
Start: 08/31/08 End: 09/30/08 Due: 09/30/09

ADVANCED Phase II Trial of Weekly vs 3 Weekly Docetaxel and Cisplatin Followed by Gemcitabine in Non-small-cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT00424853 Org: User:
Start: 05/31/05 End: 08/31/08 Due: 08/31/09

Efficacy and Safety of Surinabant Treatment as an Aid to Smoking Cessation (SURSMOKE)

Phase: N/A Priority: Normal
NCT ID: NCT00432575 Org: User:
Start: 01/31/07 End: 04/30/08 Due: 04/30/09

Study of a Pneumococcal Conjugate Vaccine in Adults Aged 50 to 84 Years.

Phase: N/A Priority: Normal
NCT ID: NCT04583618 Org: User:
Start: 10/08/20 End: 01/20/22 Due: 01/20/23

Pharmacokinetic Study to Compare Itepekimab Exposure When Administered With an Autoinjector Versus Prefilled Syringe

Phase: N/A Priority: Normal
NCT ID: NCT06114238 Org: User:
Start: 09/16/21 End: 03/08/22 Due: 03/08/23

Study in Paediatric Patients With Atopic Dermatitis Treated With Dupilumab in Spain

Phase: N/A Priority: Normal
NCT ID: NCT06415175 Org: User:
Start: 11/14/24 End: 11/23/27 Due: 11/23/28

Comparison of the Ability of Glulisine With Lispro to Control Type 1 Diabetes Mellitus in Children and Adolescents

Phase: N/A Priority: Normal
NCT ID: NCT00115570 Org: User:
Start: 04/30/05 End: 11/30/06 Due: 11/30/07

Treatment of Larotaxel/Docetaxel, +/- Trastuzumab, After Anthracycline-cyclophosphamide in Breast Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT00485979 Org: User:
Start: 06/30/07 End: 08/31/10 Due: 08/31/11

Evaluation of Pharmacokinetics, Safety, and Preliminary Efficacy of Isatuximab in Chinese Patients With Relapsed and/or Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT03733717 Org: User:
Start: 10/22/18 End: 08/25/23 Due: 08/25/24